Le Lézard
Classified in: Health
Subject: AWD

Colorado Urology Announces Dr. John C. Kefer's Designation As A UroLift® Center Of Excellence


OWINGS MILLS, Md., June 11, 2019 /PRNewswire/ -- Colorado Urology announced that John C. Kefer, M.D., Ph.D., has been designated as a UroLift® Center of Excellence by NeoTract, a wholly owned subsidiary of Teleflex Incorporated, whose focus is on addressing unmet needs in the field of urology. The designation recognizes that Dr. Kefer has achieved a high level of training and experience with the UroLift® System and demonstrates a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia or BPH. Dr. Kefer is the first urologist in the Denver metro area to achieve this designation.

Colorado Urology

"The UroLift System is a breakthrough minimally invasive treatment that typically takes less than an hour and can offer multiple benefits for men with enlarged prostate ? no cutting, heating, or removal of tissue, minimal downtime, no compromise of sexual function, and no need for continued medications," said Dr. Kefer, who sees patients in Colorado Urology's Lafayette and Westminster offices. "I am proud to be a national leader offering this treatment option for men."

Nearly 40 million men in the United States are affected by an enlarged prostate, or BPH. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness, and headaches, prompting many patients to stop using the drugs.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief.1 In February 2019, NeoTract announced that 100,000 patients globally have been treated with its minimally invasive UroLift System.

Dr. Kefer is a board-certified urologist who completed his residency and fellowship at the prestigious Cleveland Clinic. His practice interests include minimally invasive management of prostate cancer and kidney cancer, BPH/prostate enlargement and prostate health, single-site, no-scalpel vasectomies, treatment and prevention of kidney stones, urinary incontinence in women and men, and sexual dysfunction. He is a member of the American Urologic Association, a member of the Colorado Urology Executive Council, and is Co-director of Urological Robotic Surgery at Exempla Good Samaritan Medical Center.

Contact information for John C. Kefer M.D.:
Community Physicians Pavilion
300 Exempla Circle, Suite 250
Lafayette, CO 80026
720-536-3011

St. Anthony North Health Campus
500 W. 14th Avenue, Suite 220
Westminster, CO 80023
720-227-0977

For more information about BPH and the UroLift Treatment offered at Colorado Urology, men can visit https://www.coloradouro.com/specialties/bph-enlarged-prostate/minimally-invasive-treatments-for-bph/the-urolift-system-for-bph/.  

About Colorado Urology

Colorado Urology is Eastern Colorado's premier urology practice, which was formed when Advanced Urology, Alpine Urology, and Foothills Urology became one urology group in April 2019.  The group provides a broad array of urologic services, and its integrated approach to urologic care provides patients with access to experienced specialists, a comprehensive support team of healthcare professionals, innovative diagnostic tools, and highly advanced treatments and therapies.  Colorado Urology operates 11 medical offices throughout the Denver metro and Boulder areas, including Aurora, Lone Tree/Parker, and in the Foothills area with offices in Golden, and Evergreen, and has 17 urologists and more than 130 employees. 

Colorado Urology is an affiliate of United Urology Group, a management services organization whose member groups of urology practices today also include Chesapeake Urology, with 25 offices located throughout Maryland and Delaware, and Tennessee Urology with 11 locations in Knoxville and surrounding counties. United Urology's vision is to support the creation of a national network of urology affiliates, which will enable urologists to better meet the needs of their patients by utilizing the financial and operational strengths of United Urology.

Media Contact:

Patricia Schnably, Vice President, Marketing & Communications
United Urology Group
25 Crossroads Drive, Suite 306, Owings Mills, MD 21117
443-738-8107
[email protected]

* https://www.urolift.com/centers-of-excellence
1 Roehrborn et al. Can J. Urology 2017

 

SOURCE Colorado Urology


These press releases may also interest you

at 07:35
Endeavor BioMedicines, Inc. ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today announced the closing of a $132.5...

at 07:30
BioArctic AB's (publ) partner Eisai today published the preliminary global revenue for Leqembi during the first quarter 2024, in conjunction with their partner Biogen's first quarter report. In total, sales of JPY 2.83 billion were recorded in the...

at 07:25
RxLightning, creator of the industry's leading platform for streamlining specialty medication access and affordability, is proud to have reached a number of meaningful milestones in the last year ? including significant increases in provider users,...

at 07:12
Highlights from Chiesi Group's 2023 financial report: Sales increased to over ?3 billion, up 10% compared to 2022 (+12% @CER), driven by the Rare business unit growth (65% @CER), and steady growth of all products in all its Regions24% of 2023 sales...

at 07:05
Av?sis and Harmony Health have joined forces to bridge oral healthcare gaps for underserved Medicaid populations with special healthcare needs. The pilot aims to revolutionize preventive dentistry by harnessing the power of real-time salivary testing...

at 07:05
United Therapeutics Corporation , announced today that it will report its first quarter 2024 financial results before the market opens on Wednesday, May 1, 2024. A press release detailing the quarterly results will be issued that day at approximately...



News published on and distributed by: